SER-109
Seres Therapeutics
['$mcrb', 'seres therap']
$mcrb $nsrgy seres therapeutics &amp; nestl health science present results from ecospor iv phase 3 study of vowst , a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at the digestive disease week (ddw) meeting - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities